Neusignal Therapeutics株式会社
Tokyo, JP · 6 known investors
Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.
Founders & leadership
有達
有本 達代表取締役 (Representative Director/CEO)
Investors · 6
Frequently asked questions
- What does Neusignal Therapeutics株式会社 do?
- Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.
- Who founded Neusignal Therapeutics株式会社?
- Neusignal Therapeutics株式会社 was founded by 有本 達.
- Who are Neusignal Therapeutics株式会社's investors?
- Neusignal Therapeutics株式会社's investors include Angel Bridge Co.,Ltd., Red Capital, Fast Track Initiative, Keio Innovation Initiative, Nippon Venture Capital, The Gogin Capital.
- Where is Neusignal Therapeutics株式会社 headquartered?
- Neusignal Therapeutics株式会社 is headquartered in Tokyo, JP.